Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: This study evaluated the immunomodulatory effects and clinical efficacy of Chinese herbal injections (CHIs) combined with transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients using cumulative logit regression and Bayesian network meta-analysis.
Methods: A systematic review of 48 randomized controlled trials (RCTs) involving 4,293 HCC patients was conducted using PubMed, Cochrane Library, EMBASE, Scopus, and Google Scholar. Outcomes included immune markers (CD3+, CD4+, CD8+, CD4+/CD8+ ratio, and NK cells), clinical response rate, and overall survival (6-month, 1-year, and 2-year). Cumulative logit regression and Bayesian network meta-analysis were applied to synthesize ordinal and continuous outcomes.
Results: Compared to TACE alone, Aidi, Compound Kushen, and Huachansu significantly enhanced the immune function. Aidi increased CD3+ T cells (MD = 10.95, 95% CI: 8.04-13.86), CD4+ T cells (MD = 7.13, 4.37-9.89), CD4+/CD8+ ratio (MD = 0.31, 0.20-0.41), and NK cells (MD = 6.30, 4.49-8.12), while Compound Kushen showed the highest CD4+/CD8+ improvement (MD = 0.47, 0.37-0.56) and NK cell elevation (MD = 9.11, 7.32-10.91). Huachansu increased CD3+ T cells (MD = 8.74, 4.43-13.06) and CD4+ T cells (MD = 8.00, 4.21-11.80). For clinical outcomes, Compound Kushen (HR = 2.57, 1.9-3.59) and Aidi (HR = 2.28, 1.68-3.18) improved clinical response rates versus TACE. Aidi enhanced 6-month (OR = 2.57, 1.44-4.56) and 1-year survival (OR = 2.46, 1.56-3.88), whereas Huachansu (OR = 3.47, 2.42-4.97) and Compound Kushen (OR = 2.91, 1.07-7.89) improved 2-year survival.
Conclusion: Aidi, Compound Kushen, and Huachansu enhance immune function and survival in HCC patients when combined with TACE. Compound Kushen showed the most significant immunomodulatory effects, while Aidi and Huachansu improved short- and long-term survival, respectively. Further high-quality head-to-head RCTs are required to validate these results.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12006906 | PMC |
| http://dx.doi.org/10.3389/fmed.2025.1567137 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring Compound Kushen Injection's Anticancer Properties in Hepatocellular Carcinoma: An Integrated Approach of Network Pharmacology, Bioinformatics, and Experimental Validation.
Curr Drug Res Rev
August 2025
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 102488, China.
Background: Hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer, is a malignant neoplasm that originates within the liver. Conventional treatment modalities frequently result in less than satisfactory outcomes, primarily attributed to the intricate physiological and pathological contexts. Compound Kushen Injection (CKI), formulated from the botanicals Sophora flavescens and Atractylodes macrocephala, is employed as a supplementary therapy in the treatment of advanced-stage malignant tumors, including HCC.
View Article and Find Full Text PDFCompound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress.
Phytomedicine
August 2025
Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, PR China; Research Center for Lifespan Health, Wuhan University, Wuhan, Hubei, 430071, PR China. Electronic address:
Background: Multiple myeloma (MM) is a plasma cell malignancy that remains incurable due to inevitable relapse and poor treatment tolerance. Compound Kushen Injection (CKI), a traditional Chinese medicinal formulation, has been reported to exert anti-tumor effects in various cancers, but its efficacy and mechanisms in MM remain unclear.
Purpose: This study aimed to elucidate the anti-MM mechanisms of CKI, focusing on its induction of DNA damage response (DDR) and endoplasmic reticulum (ER) stress, and to assess synergy with proteasome inhibitors (PIs).
The therapeutic mechanisms of Compound Kushen Injection in relieving cancer-induced bone pain by targeting Nav1.7 and microglial activation.
J Ethnopharmacol
August 2025
Beijing Zhendong Guangming Pharmaceutical Research Institute, Beijing, 100085, China. Electronic address:
Ethnopharmacological Relevance: In traditional Chinese medicine (TCM) theory, Compound Kushen Injection (CKI) possesses multiple therapeutic effects, including heat-clearing, detoxification, blood-cooling, dampness-resolving, and pain relief. CKI has been used clinically for 30 years as an adjunctive drug alongside chemotherapy and radiotherapy for cancer treatment. However, the effects of CKI on cancer-induced bone pain (CIBP) and potential mechanisms remain poorly understood.
View Article and Find Full Text PDFPrognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection.
World J Gastrointest Oncol
July 2025
The First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, Anhui Province, China.
Background: Advanced hepatocellular carcinoma (HCC) with ascites (AS) lacks reliable biomarkers for predicting treatment outcomes. The combined prognostic value of the systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) remains underexplored for novel therapies.
Aim: To evaluate the clinical efficacy of combining intraperitoneal compound Kushen injection (CKI) with immunotherapy in patients with advanced HCC using a scoring system that combines SII and PNI.
Formononetin From Sophora flavescens Aiton Alleviates Atopic Dermatitis by Suppressing Neutrophil Extracellular Traps.
Phytother Res
August 2025
Institute of Traditional Chinese Medicine and Stem Cell Research, College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with limited effective treatment. Sophora flavescens Aiton (Kushen) exhibits anti-inflammatory properties, but its key active components and mechanisms against AD remain unclear. This study aimed to identify its therapeutic compounds and the underlying molecular mechanisms.
View Article and Find Full Text PDF